Summary & Overview
CPT 93312: Transesophageal Echocardiography, Real-Time Imaging
CPT code 93312 is a critical billing code for transesophageal echocardiography, a specialized cardiovascular imaging procedure that provides real-time, two-dimensional visualization of the heart via an esophageal ultrasound probe. This procedure is widely used in hospitals and ambulatory surgical centers to diagnose and monitor complex cardiac conditions, offering superior detail compared to traditional transthoracic echocardiography.
Major national payers, including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare, recognize and reimburse for this service, making it a key component of cardiovascular care across the United States. The publication provides an overview of payer coverage, common billing modifiers, and associated clinical taxonomies, helping readers understand the procedural context and reimbursement landscape.
Readers will gain insights into the clinical indications for 93312, relevant ICD-10 diagnoses, and related CPT codes for echocardiographic services. The article also highlights policy updates, coding benchmarks, and the importance of accurate documentation for compliance and reimbursement. This summary serves as a resource for healthcare professionals, administrators, and policy analysts seeking clarity on the use and billing of transesophageal echocardiography.
CPT Code Overview
CPT code 93312 represents transesophageal echocardiography, a real-time imaging procedure used to assess the heart and its structures. This cardiovascular procedure utilizes a specialized ultrasound probe inserted into the esophagus to obtain detailed two-dimensional images of the heart, with or without M-mode recording. The service is typically performed in varied settings, including hospital outpatient departments and ambulatory surgical centers (ASC). This advanced imaging technique is essential for diagnosing complex cardiac conditions and guiding clinical management.
Clinical & Coding Specifications
Clinical Context
A patient is admitted to the hospital with symptoms suggestive of sepsis, such as fever, hypotension, and evidence of organ dysfunction. The clinical team suspects a cardiac complication, such as endocarditis or myocardial involvement, due to the underlying infection. To evaluate cardiac structure and function, a transesophageal echocardiography is ordered. The procedure involves inserting an ultrasound probe into the esophagus to obtain real-time two-dimensional images of the heart, with or without M-mode recording. The test is performed in a hospital outpatient setting or ambulatory surgical center by a cardiovascular specialist, and image documentation is included for diagnostic purposes. The results assist in guiding further management of the patient’s infection and cardiac status.
Coding Specifications
-
Modifiers:
- Modifier
26: Used when reporting only the professional component (interpretation and report) of the procedure. - Modifier
TC: Used when reporting only the technical component (equipment and staff) of the procedure. - Modifier
59: Indicates a distinct procedural service, used when the procedure is separate from other services performed on the same day. - Modifier
76: Used when the procedure is repeated by the same physician.
- Modifier
-
Provider Taxonomies:
| Taxonomy Code | Specialty |
|---|---|
207RC0000X | Cardiovascular Disease Physician |
207RI0011X | Interventional Cardiology Physician |
207RC0200X | Cardiac Electrophysiology Physician |
207R00000X | Internal Medicine Physician |
207ZP0102X | Pediatric Cardiology Physician |
Related Diagnoses
-
A02.1– Salmonella sepsis- Relevant for patients with sepsis due to Salmonella, where cardiac complications may warrant echocardiographic evaluation.
-
A18.84– Tuberculosis of heart- Used when tuberculosis affects the heart, requiring detailed imaging to assess structural involvement.
-
A22.7– Anthrax sepsis- Indicates sepsis from anthrax, which can impact cardiac function and necessitate echocardiography.
-
A26.7– Erysipelothrix sepsis- Sepsis from Erysipelothrix may lead to endocarditis or other cardiac issues.
-
A32.7– Listerial sepsis- Listeria sepsis can cause cardiac complications, justifying the use of transesophageal echocardiography.
-
A40.0– Sepsis due to streptococcus, group A- Group A streptococcal sepsis may result in endocarditis or myocardial involvement.
-
A40.1– Sepsis due to streptococcus, group B- Group B streptococcal sepsis can affect the heart, requiring imaging.
-
A40.3– Sepsis due to Streptococcus pneumoniae- Pneumococcal sepsis may lead to cardiac complications.
-
A40.8– Other streptococcal sepsis- Other streptococcal infections may necessitate cardiac evaluation.
-
A41.01– Sepsis due to Methicillin susceptible Staphylococcus aureus- Staphylococcal sepsis is a common cause of endocarditis.
-
A41.02– Sepsis due to Methicillin resistant Staphylococcus aureus- MRSA sepsis often requires cardiac imaging to rule out endocarditis.
-
A41.1– Sepsis due to other specified staphylococcus- Other staphylococcal sepsis may involve the heart.
-
A41.3– Sepsis due to Hemophilus influenzae- Hemophilus sepsis can cause cardiac complications.
-
A41.4– Sepsis due to anaerobes- Anaerobic sepsis may affect cardiac structures.
-
A41.50– Gram-negative sepsis, unspecified- Unspecified gram-negative sepsis may require echocardiographic assessment.
-
A41.51– Sepsis due to Serratia- Serratia sepsis can lead to endocarditis.
-
A41.52– Sepsis due to unspecified gram-negative organisms- Used when the specific gram-negative organism is not identified.
-
A41.53– Sepsis due to Serratia (again)- Duplicate code for Serratia sepsis.
-
A41.59– Other Gram-negative sepsis- Other gram-negative sepsis may involve the heart.
-
A41.81– Sepsis due to Enterococcus- Enterococcal sepsis is a risk factor for endocarditis.
-
A41.89– Other specified sepsis- Used for sepsis from other specified organisms.
-
A41.9– Sepsis, unspecified organism- Used when the causative organism is not identified.
-
A42.7– Actinomycotic sepsis- Actinomyces sepsis may cause cardiac involvement.
-
A52.01– Syphilitic aneurysm of aorta- Syphilitic aortic aneurysm requires detailed cardiac imaging.
-
A52.02– Syphilitic aortitis- Syphilitic inflammation of the aorta may be evaluated with echocardiography.
Related CPT Codes
-
93320– Doppler echocardiography, pulsed wave and/or continuous wave with spectral display- Often performed in conjunction with
93312to assess blood flow and velocity within the heart.
- Often performed in conjunction with
-
93325– Doppler echocardiography color flow velocity mapping- Used alongside
93312to visualize blood flow patterns and detect abnormal flow.
- Used alongside
-
93350– Stress echocardiography- Alternative to
93312for evaluating cardiac function under stress; not typically performed transesophageally.
- Alternative to
-
93306– Echocardiography, transthoracic, complete- Non-invasive alternative to
93312; used when transesophageal imaging is not required.
- Non-invasive alternative to
-
93351– Stress echocardiography, including interpretation and report- Combines stress testing with echocardiographic imaging; may be used instead of
93312in certain clinical scenarios.
- Combines stress testing with echocardiographic imaging; may be used instead of
Codes 93320 and 93325 are commonly used together with 93312 to provide comprehensive assessment of cardiac function and blood flow. Codes 93350, 93306, and 93351 are alternatives depending on clinical indication and patient suitability.
National Reimbursement Benchmarks
Medicare's national mean rate for CPT code 93312 is $165.86, which is significantly lower than the BUCA (Blue Cross Blue Shield, UnitedHealth Group, Cigna, and Aetna) commercial average of $234.57. Among individual commercial payers, Cigna and UnitedHealth Group have the highest mean rates at $293.65 and $288.20, respectively, while Aetna is the lowest at $192.64.
Rate dispersion, measured by the difference between the 75th and 25th percentiles, varies notably across payers. Medicare shows the widest spread at $121.50, indicating substantial variability in reimbursement. Cigna and UnitedHealth Group also exhibit wide dispersions ($141.33 and $143.17, respectively), while Aetna has the tightest range at $73.75, suggesting more consistent rates. The table and chart below present the full breakdown of national benchmarks for each payer.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.